June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
Regulation of Cataractogenesis by Hydrogen Sulfide-NSAID Hybrid Compounds in Cultured Bovine Lenses
Author Affiliations & Notes
  • Catherine A Opere
    Pharmacy Sciences, Creighton University, Omaha, Nebraska, United States
  • Leonce N Maffofou N.
    Pharmacy Sciences, Creighton University, Omaha, Nebraska, United States
  • Segewkal Heruye
    Pharmacy Sciences, Creighton University, Omaha, Nebraska, United States
  • Anthony Baker
    Pharmacy Sciences, Creighton University, Omaha, Nebraska, United States
  • Neetu Singh
    Pharmacy Sciences, Creighton University, Omaha, Nebraska, United States
  • Ya Fatou Njie-Mbye
    Texas Southern University, Houston, Texas, United States
  • Sunny Ohia
    Texas Southern University, Houston, Texas, United States
  • Footnotes
    Commercial Relationships   Catherine Opere, None; Leonce N Maffofou N., None; Segewkal Heruye, None; Anthony Baker, None; Neetu Singh, None; Ya Fatou Njie-Mbye, None; Sunny Ohia, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 1025. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Catherine A Opere, Leonce N Maffofou N., Segewkal Heruye, Anthony Baker, Neetu Singh, Ya Fatou Njie-Mbye, Sunny Ohia; Regulation of Cataractogenesis by Hydrogen Sulfide-NSAID Hybrid Compounds in Cultured Bovine Lenses. Invest. Ophthalmol. Vis. Sci. 2020;61(7):1025.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Hydrogen sulfide (H2S) releasing compounds and NSAIDs can mitigate cataractogenesis in vitro and in vivo (Zhang et al., Mol Vis, 14:862, 2008; Harding JJ et al., Acta Ophthalmol, 67:518, 1989). However, the role of NSAID-H2S-releasing hybrid compounds on cataractogenesis has not been elucidated. In the present study, we compared the pharmacological effects of ATB343 and ATB337 on cataractogenesis in cultured bovine lenses and on lenticular antioxidants concentrations.

Methods : Freshly isolated bovine lenses were cultured in a DMEM buffer solution as follows: Group I: Control (DMEM); Group II: H2O2 (10 mM); Groups III-V: ATB343 (10-7M); ATB337 (10-7M); ascorbic acid (AA; 10-3M) in presence and absence of H2O2. Lenses were incubated and were qualitatively and quantitatively assessed at 3, 6, 24, 48 and 72 h-time points by photographic captures and measurement of transmittance using a plate reader (Synergy H1 hybrid). Lenticular glutathione (GSH) and superoxide dismutase (SOD) were measured using Cayman Assay Kits

Results : DMEM-cultured lenses elicited a time-dependent decrease in transmittance (420nm) and a corresponding loss of lens optical clarity up to 72 h. Unlike ATB343 (10-7M) and AA (10 mM) which attenuated time-dependent lens degradation up to 24 h, ATB337 (10-7M) decreased time-dependent transmittance, achieving an inhibition of 34.7 ± 1.12% (n=12; p<0.01) after 72 h. H2O2 (10 mM) reduced transmittance in a time-dependent manner, attaining an inhibition of 42.0 ± 1.0% (n=12; p<0.01) after 72 h. After 48 h, ATB343 (10-7M) and ATB337 (10-7M) enhanced time-dependent GSH depletion by 3.6%± 0.05% (n=3; p<0.05) and 2.7± 0.5% (n=3; p<0.05) and H2O2-induced GSH depletion by 12.3± 0.1% (n=3; p<0.01) and 8.7 ±0.4% (n=3; p<0.05), respectively. However, ATB343 enhanced SOD depletion by 35.3 ± 2.7% (n=3; p<0.001) but attenuated H2O2-induced SOD depletion by 56.6±3.1% (n=3; p<0.001) (t=48 h). Similarly, ATB337 enhanced time-dependent loss in SOD by 48.9 ± 4.4% (n=3; p<0.001) but reversed H2O2-induced SOD loss by 31.8 ± 4.9% (n=3; p<0.001) (t=48 h).

Conclusions : The NSAID-H2S hybrid compounds, ATB343 and ATB337 can partially protect cultured bovine lenses from cataract formation, presumably via an effect on lenticular SOD concentrations.

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×